nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Tonsillitis—Mitoxantrone—lymphatic system cancer	0.0407	0.0407	CcSEcCtD
Cefprozil—Nephropathy toxic—Teniposide—lymphatic system cancer	0.0342	0.0342	CcSEcCtD
Cefprozil—Nephropathy toxic—Bleomycin—lymphatic system cancer	0.022	0.022	CcSEcCtD
Cefprozil—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0214	0.0214	CcSEcCtD
Cefprozil—Nephropathy toxic—Carmustine—lymphatic system cancer	0.0192	0.0192	CcSEcCtD
Cefprozil—Nephropathy toxic—Mitoxantrone—lymphatic system cancer	0.0179	0.0179	CcSEcCtD
Cefprozil—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Cefprozil—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Cefprozil—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Cefprozil—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Cefprozil—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Cefprozil—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Cefprozil—Pancytopenia—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Cefprozil—Neutropenia—Teniposide—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Cefprozil—Pancytopenia—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Cefprozil—Neutropenia—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Cefprozil—Haemoglobin—Teniposide—lymphatic system cancer	0.00991	0.00991	CcSEcCtD
Cefprozil—Haemorrhage—Teniposide—lymphatic system cancer	0.00986	0.00986	CcSEcCtD
Cefprozil—Blood urea increased—Mitoxantrone—lymphatic system cancer	0.0097	0.0097	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00957	0.00957	CcSEcCtD
Cefprozil—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00951	0.00951	CcSEcCtD
Cefprozil—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00931	0.00931	CcSEcCtD
Cefprozil—Haemoglobin—Fludarabine—lymphatic system cancer	0.00871	0.00871	CcSEcCtD
Cefprozil—Haemorrhage—Fludarabine—lymphatic system cancer	0.00867	0.00867	CcSEcCtD
Cefprozil—Pharyngitis—Fludarabine—lymphatic system cancer	0.0086	0.0086	CcSEcCtD
Cefprozil—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0082	0.0082	CcSEcCtD
Cefprozil—Agitation—Teniposide—lymphatic system cancer	0.00789	0.00789	CcSEcCtD
Cefprozil—Pancytopenia—Bleomycin—lymphatic system cancer	0.00754	0.00754	CcSEcCtD
Cefprozil—Confusional state—Teniposide—lymphatic system cancer	0.00707	0.00707	CcSEcCtD
Cefprozil—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.007	0.007	CcSEcCtD
Cefprozil—Agitation—Fludarabine—lymphatic system cancer	0.00694	0.00694	CcSEcCtD
Cefprozil—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Cefprozil—Pruritus—Mechlorethamine—lymphatic system cancer	0.00673	0.00673	CcSEcCtD
Cefprozil—Pancytopenia—Carmustine—lymphatic system cancer	0.00658	0.00658	CcSEcCtD
Cefprozil—Convulsion—Fludarabine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Cefprozil—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0065	0.0065	CcSEcCtD
Cefprozil—Neutropenia—Carmustine—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Cefprozil—Haemoglobin—Bleomycin—lymphatic system cancer	0.00639	0.00639	CcSEcCtD
Cefprozil—Haemorrhage—Bleomycin—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Cefprozil—Pancytopenia—Vincristine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Cefprozil—Confusional state—Fludarabine—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Cefprozil—Neutropenia—Vincristine—lymphatic system cancer	0.00619	0.00619	CcSEcCtD
Cefprozil—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Cefprozil—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00612	0.00612	CcSEcCtD
Cefprozil—Vomiting—Mechlorethamine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Cefprozil—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00603	0.00603	CcSEcCtD
Cefprozil—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00603	0.00603	CcSEcCtD
Cefprozil—Rash—Mechlorethamine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Cefprozil—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Cefprozil—Feeling abnormal—Teniposide—lymphatic system cancer	0.00578	0.00578	CcSEcCtD
Cefprozil—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Cefprozil—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Cefprozil—Nausea—Mechlorethamine—lymphatic system cancer	0.00565	0.00565	CcSEcCtD
Cefprozil—Haemoglobin—Carmustine—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Cefprozil—Urticaria—Teniposide—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Cefprozil—Haemorrhage—Carmustine—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Cefprozil—Body temperature increased—Teniposide—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Cefprozil—Abdominal pain—Teniposide—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Cefprozil—Erythema—Bleomycin—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Cefprozil—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Cefprozil—Pain—Fludarabine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Cefprozil—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Cefprozil—Hypersensitivity—Teniposide—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Cefprozil—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Cefprozil—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Cefprozil—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Cefprozil—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Cefprozil—Pruritus—Teniposide—lymphatic system cancer	0.00496	0.00496	CcSEcCtD
Cefprozil—Body temperature increased—Fludarabine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Cefprozil—Vaginal infection—Methotrexate—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Cefprozil—Erythema—Carmustine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Cefprozil—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Cefprozil—Diarrhoea—Teniposide—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Cefprozil—Confusional state—Bleomycin—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Cefprozil—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Cefprozil—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Cefprozil—Erythema—Mitoxantrone—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Cefprozil—Vomiting—Teniposide—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Cefprozil—Agitation—Carmustine—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Cefprozil—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Cefprozil—Rash—Teniposide—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Cefprozil—Dermatitis—Teniposide—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Cefprozil—Headache—Teniposide—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Cefprozil—Pruritus—Fludarabine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Cefprozil—Agitation—Vincristine—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Cefprozil—Diarrhoea—Fludarabine—lymphatic system cancer	0.00421	0.00421	CcSEcCtD
Cefprozil—Convulsion—Carmustine—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Cefprozil—Nausea—Teniposide—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Cefprozil—Convulsion—Vincristine—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Cefprozil—Confusional state—Carmustine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Cefprozil—Vomiting—Fludarabine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Cefprozil—Convulsion—Mitoxantrone—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Cefprozil—Rash—Fludarabine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Cefprozil—Dermatitis—Fludarabine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Cefprozil—Pain—Bleomycin—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Cefprozil—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Cefprozil—Headache—Fludarabine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Cefprozil—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Cefprozil—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Cefprozil—Confusional state—Mitoxantrone—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Cefprozil—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Cefprozil—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Cefprozil—Nausea—Fludarabine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Cefprozil—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Cefprozil—Urticaria—Bleomycin—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Cefprozil—Body temperature increased—Bleomycin—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Cefprozil—Insomnia—Carmustine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Cefprozil—Somnolence—Carmustine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Cefprozil—Insomnia—Vincristine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Cefprozil—Pain—Carmustine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Cefprozil—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Cefprozil—Somnolence—Mitoxantrone—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Cefprozil—Feeling abnormal—Carmustine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Cefprozil—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Cefprozil—Pain—Vincristine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Cefprozil—Pruritus—Bleomycin—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Cefprozil—Eosinophilia—Methotrexate—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Cefprozil—Pain—Mitoxantrone—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Cefprozil—Abdominal pain—Carmustine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Cefprozil—Body temperature increased—Carmustine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Cefprozil—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Cefprozil—Pancytopenia—Methotrexate—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Cefprozil—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Cefprozil—Neutropenia—Methotrexate—lymphatic system cancer	0.003	0.003	CcSEcCtD
Cefprozil—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.003	0.003	CcSEcCtD
Cefprozil—Abdominal pain—Vincristine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Cefprozil—Body temperature increased—Vincristine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Cefprozil—Urticaria—Mitoxantrone—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Cefprozil—Hypersensitivity—Carmustine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Cefprozil—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Cefprozil—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Cefprozil—Vomiting—Bleomycin—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Cefprozil—Drowsiness—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Cefprozil—Rash—Bleomycin—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Cefprozil—Dermatitis—Bleomycin—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cefprozil—Hypersensitivity—Vincristine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Cefprozil—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Cefprozil—Diarrhoea—Carmustine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Cefprozil—Nausea—Bleomycin—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Cefprozil—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Cefprozil—Dizziness—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Cefprozil—Haemoglobin—Methotrexate—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Cefprozil—Diarrhoea—Vincristine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Cefprozil—Haemorrhage—Methotrexate—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Cefprozil—Pharyngitis—Methotrexate—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Cefprozil—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Cefprozil—Vomiting—Carmustine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Cefprozil—Dizziness—Vincristine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Cefprozil—Rash—Carmustine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Cefprozil—Dermatitis—Carmustine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Cefprozil—Headache—Carmustine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Cefprozil—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Cefprozil—Vomiting—Vincristine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Cefprozil—Rash—Vincristine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Cefprozil—Dermatitis—Vincristine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Cefprozil—Headache—Vincristine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Cefprozil—Nausea—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Cefprozil—Vomiting—Mitoxantrone—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Cefprozil—Rash—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Cefprozil—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Cefprozil—Headache—Mitoxantrone—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Cefprozil—Erythema—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Cefprozil—Nausea—Vincristine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Cefprozil—Nausea—Mitoxantrone—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Cefprozil—Convulsion—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Cefprozil—Confusional state—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Cefprozil—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Cefprozil—Insomnia—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cefprozil—Somnolence—Methotrexate—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cefprozil—Pain—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cefprozil—Feeling abnormal—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cefprozil—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cefprozil—Urticaria—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cefprozil—Abdominal pain—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cefprozil—Body temperature increased—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cefprozil—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cefprozil—Pruritus—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cefprozil—Diarrhoea—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Cefprozil—Dizziness—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cefprozil—Vomiting—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cefprozil—Rash—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Cefprozil—Dermatitis—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Cefprozil—Headache—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cefprozil—Nausea—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
